BIG
WST icon

Bellwether Investment Group’s West Pharmaceutical WST Stock Holding History

Bellwether Investment Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-193
Closed -$16K – 624
2017
Q1 		$16K Sell
193
-7
-4% -$585 0.04% 377
2016
Q4 		$17K Buy
+200
New +$15.7K 0.02% 499

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Bellwether Investment Group's WST Position: Q2 2017 in Review

Bellwether Investment Group sold out of West Pharmaceutical (WST) in Q2 2017, closing a stake of 193 shares — an estimated $16K sold.

Bellwether Investment Group first reported a position in WST in Q4 2016 and held it in 2 quarters. The position peaked at $17K in Q4 2016. 309 funds tracked by Wall St. Rank hold WST as of Q2 2017.

  • Bellwether Investment Group reported no remaining West Pharmaceutical position as of Q2 2017 after selling out during the quarter.
  • Bellwether Investment Group sold 193 West Pharmaceutical shares in Q2 2017, an estimated $16K.
  • Bellwether Investment Group first reported a position in West Pharmaceutical in Q4 2016 and held it in 2 quarters.
  • Bellwether Investment Group's West Pharmaceutical position peaked at $17K in Q4 2016.
  • 309 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Bellwether Investment Group's 13F filing for Q2 2017, filed 8 Aug 2017.